Total medical devices industry cross border deals worth $545.3m were announced globally for February 2021, with the $108m private equity deal with Mainstay Medical International being the sector’s biggest investment, according to GlobalData’s deals database.
The value marked a decrease of 83.9% over the previous month of $3.38bn and a drop of 80.9% when compared with the last 12-month average of $2.86bn.
In terms of number of cross border deals, the sector saw a drop of 7.69% with 36 deals in February 2021 when compared to the last 12-month average of 39 deals.
In value terms, North America led the activity with cross border deals worth $305.47m in February 2021.
